Document Detail

Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
MedLine Citation:
PMID:  7444377     Owner:  NLM     Status:  MEDLINE    
Severe acquired antithrombin III (AT III) deficiency was observed in a patient with severe pre-eclamptic toxaemia. Plasma AT III concentration of 0.25 U/ml was found in both functional and immunological assays. The patient was treated with human AT III concentrate as a result of the development of progressive disseminated intravascular coagulation (DIC), the further deterioration of renal function, the risk for thromboembolic complications and the possible adverse effects of heparin therapy. The selective correction of AT III activity resulted in a rapid disappearance of coagulation abnormalities. The patient underwent uncomplicated caesarian section. This observation indicates that acquired severe AT III deficiency may occur as an early feature of DIC in severe pre-eclamptic toxaemia.
H R Büller; A H Weenink; P E Treffers; L H Kahlé; H A Otten; J W ten Cate
Related Documents :
8091377 - Incidence of factor viii inhibitor development in hemophilia a patients treated with le...
15916687 - The course of adamts-13 activity and inhibitor titre in the treatment of thrombotic thr...
3106577 - Factor viii r:ag as a prognostic parameter in intracranial haemorrhage.
3373617 - Study of the factors affecting blood viscosity in patients with thromboangiitis obliter...
3789617 - The relevance of microbiology in the management of anorectal sepsis.
24096347 - Dengue fever mimicking acute appendicitis: a case report.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Scandinavian journal of haematology     Volume:  25     ISSN:  0036-553X     ISO Abbreviation:  Scand J Haematol     Publication Date:  1980 Jul 
Date Detail:
Created Date:  1981-02-24     Completed Date:  1981-02-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0404507     Medline TA:  Scand J Haematol     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  81-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antithrombin III / therapeutic use
Antithrombin III Deficiency*
Blood Coagulation Tests
Disseminated Intravascular Coagulation / complications,  drug therapy
Kidney Function Tests
Pre-Eclampsia / complications*
Reg. No./Substance:
9000-94-6/Antithrombin III

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Dosage of acetylsalicylic acid for inhibition of platelet function.
Next Document:  Erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities in beta-thalassaemi...